Write your message
Volume 5, Issue 2 (Spring (Under Published) 2020)                   J Obstet Gynecol Cancer Res 2020, 5(2): 44-48 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rezaei Z, Valadan M, Zabihi Soltani E. Comparison of Serum Levels of AMH and FSH Before and After Unilateral and Bilateral Laparoscopic Ovarian Drilling in PCOS Women Referred to YAS Infertility Clinic. J Obstet Gynecol Cancer Res. 2020; 5 (2) :44-48
URL: http://jogcr.com/article-1-272-en.html
1- Department of Obstetrics and Gynecology, Yas Women General Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Department of Obstetrics and Gynecology, Yas Women General Hospital, Tehran University of Medical Sciences, Tehran, Iran , elahezbhsltn@gmail.com
Abstract:   (143 Views)
Background & Objective: Laparoscopic ovarian drilling (LOD) is a method for ovulation induction in polycystic ovary syndrome (PCOS) patients. The aim of this study was to evaluate the serum levels of anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) before and after LOD in one or two ovaries in women with PCOS.
Materials & Methods: This study was a prospective cohort study. The study population included infertile women with PCOS resistant to clomiphene referred to the Infertility Clinic of Yas Hospital. They were candidates for LOD in 2016–2017. The serum levels of AMH and FSH were measured before and after three months in two groups of unilateral and bilateral LOD. Data were analyzed using Stata software.
Results: A total of 35 female patients were enrolled in the study, 18 (51.4%) in bilateral and 17 (46%) in unilateral LOD groups; the average age of patients was 27 ± 3.4 years old. AMH levels significantly (P<0.001) decreased in both unilateral and bilateral groups after LOD. FSH levels significantly (P<0.001) increased in both groups after LOD, but this increase was higher in the unilateral group than in the bilateral group, and this difference was statistically significant (P<0.001).
Conclusion:
 It seems women with clomiphene-resistant PCOS when underwent unilateral or bilateral ovarian drilling experienced a significant decrease in AMH and a significant increase in FSH, indicating a decrease in their ovarian reserve.
Full-Text [PDF 301 kb]   (22 Downloads)    
Systematic Review: Original Research | Subject: Obstetrics and Gynecology
Received: 2020/08/2 | Accepted: 2020/09/8 | Published: 2020/10/19

References
1. Conway GS. Polycystic ovary syndrome: clinical aspects. Baillière's Clin Endocrinol Metab. 1996;1;10(2):263-79. [DOI:10.1016/S0950-351X(96)80113-3]
2. Homburg R. Polycystic ovary syndrome: induction of ovulation. Baillière's Clin Endocrinol Metab. 1996;1;10(2):281-92. [DOI:10.1016/S0950-351X(96)80127-3]
3. Şahin Y, Yirmibeş Ü, Keleştimur F, Aygen E. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome. European Eur J Obstet Gynecol Reprod Biol. 2004; 15;113(2):214-20. [DOI:10.1016/j.ejogrb.2003.09.036] [PMID]
4. Badawy A, Aal IA, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril. 2009; 1;92(3):849-52. [DOI:10.1016/j.fertnstert.2007.02.062] [PMID]
5. Farquhar C, Brown J, Marjoribanks J. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Syst Rev. 2012(6). [DOI:10.1002/14651858.CD001122.pub4]
6. Amer SA, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod. 2004; 1;19(8):1719-24. [DOI:10.1093/humrep/deh343] [PMID]
7. Kaur M, Pranesh G, Mittal M, Gahlan A, Deepika K, Shashikala T, Rao KA. Outcome of laparoscopic ovarian drilling in patients of clomiphene resistant polycystic ovarian syndrome in a tertiary care center. Int J Infertil Fetal Med. 2013; 27(4):3-2. [DOI:10.5005/jp-journals-10016-1059]
8. Mitra S, Nayak PK, Agrawal S. Laparoscopic ovarian drilling: An alternative but not the ultimate in the management of polycystic ovary syndrome. J Nat Sci Biol Med. 2015;6(1):40. [DOI:10.4103/0976-9668.149076] [PMID] [PMCID]
9. Ott J, Wirth S, Nouri K, Kurz C, Mayerhofer K, Huber JC, Tempfer CB. Luteinizing hormone and androstendione are independent predictors of ovulation after laparoscopic ovarian drilling: a retrospective cohort study. Reprod Biol Endocrinol. 2009; 7(1):153. [DOI:10.1186/1477-7827-7-153] [PMID] [PMCID]
10. Kato M, Kikuchi I, Shimaniki H, Kobori H, Aida T, Kitade M, Kumakiri J, Takeuchi H. Efficacy of laparoscopic ovarian drilling for polycystic ovary syndrome resistant to clomiphene citrate. J Obstet Gynaecol Res. 2007; 33(2):174-80. [DOI:10.1111/j.1447-0756.2007.00504.x] [PMID]
11. Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Hum Reprod. 2008; 23(3):462-77. [DOI:10.1093/humrep/dem426] [PMID]
12. El Behery MM, E Diab A, Mowafy H, Ebrahiem MA, E Shehata A. Effect of laparoscopic ovarian drilling on vascular endothelial growth factor and ovarian stromal blood flow using 3‐dimensional power Doppler. Int J Gynaecol Obstet. 2011; 112(2):119-21. [DOI:10.1016/j.ijgo.2010.08.018] [PMID]
13. Van Rooij IA, Broekmans FJ, Te Velde ER, Fauser BC, Bancsi LF, De Jong FH, Themmen AP. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002; 17(12):3065-71. [DOI:10.1093/humrep/17.12.3065] [PMID]
14. Tremellen KP, Kolo M, Gilmore A, Lekamge DN. Anti‐müllerian hormone as a marker of ovarian reserve. Aust N Z J Obstet Gynaecol. 2005; 45(1):20-4. [DOI:10.1111/j.1479-828X.2005.00332.x] [PMID]
15. Iwase A, Hirokawa W, Goto M, Takikawa S, Nagatomo Y, Nakahara T, Manabe S, Kikkawa F. Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil Steril. 2010; 94(7):2846-9. [DOI:10.1016/j.fertnstert.2010.06.010] [PMID]
16. Fiçicioǧlu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil. Steril. 2006; 85(3):592-6. [DOI:10.1016/j.fertnstert.2005.09.019] [PMID]
17. Elgindy EA, El-Haieg DO, El-Sebaey A. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients. Fertil. Steril. 2008; 89(6):1670-6. [DOI:10.1016/j.fertnstert.2007.05.040] [PMID]
18. Riggs RM, Duran EH, Baker MW, Kimble TD, Hobeika E, Yin L, Matos-Bodden L, Leader B, Stadtmauer L. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol. 2008; 199(2):202-e1. [DOI:10.1016/j.ajog.2008.05.004] [PMID]
19. Amer SA, Laird S, Ledger WL, Li TC. Effect of laparoscopic ovarian diathermy on circulating inhibin B in women with anovulatory polycystic ovary syndrome. Hum Reprod. 2007; 22(2):389-94. Epub 2006/10/07. [DOI:10.1093/humrep/del373] [PMID]
20. Kandil M, Selim M. Hormonal and sonographic assessment of ovarian reserve before and after laparoscopic ovarian drilling in polycystic ovary syndrome. BJOG. 2005.112(10):1427-30. Epub 2005/09/20. [DOI:10.1111/j.1471-0528.2005.00684.x] [PMID]
21. Smeenk JM, Sweep FC, Zielhuis GA, Kremer JA, Thomas CM, Braat DD. Antimüllerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection. Fertil. Steril. 2007; 87(1):223-6. [DOI:10.1016/j.fertnstert.2006.06.019] [PMID]
22. Gleicher N, Weghofer A, Barad DH. Defining ovarian reserve to better understand ovarian aging. Reprod Biol Endocrinol. 2011; 9(1):23. [DOI:10.1186/1477-7827-9-23] [PMID] [PMCID]
23. Sunj M, Canic T, Jeroncic A, Karelovic D, Tandara M, Juric S, et al. Anti-Mullerian hormone, testosterone and free androgen index following the dose-adjusted unilateral diathermy in women with polycystic ovary syndrome. Eur J Obstet Gynecol. 2014; 179:163-9. [DOI:10.1016/j.ejogrb.2014.05.011] [PMID]
24. Rezk M, Emarh M, Alhalaby A. Anti-Müllerian hormone and luteinizing hormone for prediction of spontaneous ovulation after laparoscopic ovarian drilling in clomiphene-resistant polycystic ovary syndrome. Middle East Fertil Soc J. 2016; 21(2):91-5. [DOI:10.1016/j.mefs.2015.09.003]
25. Farzadi L, Nouri M, Ghojazadeh M, Mohiti M, Aghadavod E. Evaluation of ovarian reserve after laparoscopic surgery in patients with polycystic ovary syndrome. BioImpacts: BI. 2012; 2(3):167.
26. Barad DH, Weghofer A, Gleicher N. Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function. Fertil Steril. 2009; 91(4):1553-5. [DOI:10.1016/j.fertnstert.2008.09.069] [PMID]
27. Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab. 2004; 89(1):318-23. [DOI:10.1210/jc.2003-030932] [PMID]
28. Amer SA, Li TC, Ledger WL. The value of measuring anti-Müllerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy. Hum Reprod. 2009; 24(11):2760-6. [DOI:10.1093/humrep/dep271] [PMID]
29. Ficicioglu C, Cenksoy PO, Yildirim G, Kaspar C. Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis. Gynecol Endocrinol. 2014; 30(5):372-6. [DOI:10.3109/09513590.2014.887064] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.